Our Businesses
-
MDS is a global life sciences company with US$1.1 billion in net revenues. We are a publicly traded company on the TSX and NYSE.
- We have 5,500 employees worldwide and more than 95% of the Company's revenues are generated from global markets.
- The Company operates in 29 countries and distributes products to 62 countries with its end markets growing 7% - 10% annually.
- MDS is a leading innovator in providing products and services used to develop new drugs and technologies to diagnose, prevent and treat diseases.
- We have three business units with market-leading positions. They are MDS Analytical Technologies (analytical instruments), MDS Nordion (molecular imaging) and MDS Pharma Services (contract research).
- We serve a vast array of global clients - they include pharmaceutical and biotech companies, academic research facilities, government agencies, hospitals, clinics, and global research facilities.
Background:
MDS is making changes to strengthen the Company's position as a leading innovator in global life sciences markets. The Company is executing a growth strategy that focuses on opportunity within the fast growing life sciences markets served by the Company's three core businesses, MDS Analytical Technologies, MDS Nordion, and MDS Pharma Services. These businesses are global market leaders in analytical instruments, molecular imaging, radiotherapeutics and pharmaceutical contract research.